SPDR S&P MidCap 400 ETFNYSEArca
After hours: 282.46-0.05 (-0.02%) as of 4:52 PM EDT
|Bid||275.01 x 300|
|52wk Range||216.91 - 282.75|
|Day's Range||280.30 - 282.75|
|Ask||286.86 x 100|
|Avg Vol (3m)||1,742,826|
As of 4:00 PM EDT. Market closed.
- Market Realist•yesterday
Administered through the proprietary inhalation system, United Therapeutics’ (UTHR) Tyvaso is generally used as an end-stage therapy for pulmonary arterial hypertension (or PAH).